Manerix · DIN 00899356 · 150 mg · tablet
General benefitDormant since July 31, 2026 · checked November 17, 2026 · What does dormant mean?
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Manerix · DIN 00899356
Manufacturer: Meda AB; listing date 1996-10-01
Health Canada: Dormant since 2026-07-31 · brand MANERIX · ATC N06AG02 MOCLOBEMIDE · form Tablet · route Oral · ingredients MOCLOBEMIDE 150 MG · company Bausch health, canada inc. · schedule Prescription
Ministry pays: $0.5295 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00899356)
Source record
DIN 00899356: Manerix
Raw flags: sec3=Y
Item: 281604067; group id 465; item number 1171; lccId None; manufacturer id MAB
Source form: Tab; strength: 150mg
Recorded listing: General benefit
Source prices (unrounded): $0.9126; ministry $0.5295
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00899356
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13256
Interchangeable products
Moclobemide · DIN 02232150 · $0.5295
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Dormant since July 31, 2026 — choose a marketed DIN from the same-category list.